autosomal recessive Parkinson disease 14

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Print

Disease Overview

A rare neurodegenerative disease usually presenting before the age of 30 and which is characterized by dystonia, L-dopa-responsive parkinsonism, pyramidal signs and rapid cognitive decline.


Synonyms

  • PARK14
  • PLA2G6 hereditary late onset Parkinson disease
  • PLA2G6-related dystonia-parkinsonism
  • Parkinson disease 14, autosomal recessive
  • adult-onset dystonia - parkinsonism
  • autosomal recessive Parkinson disease type 14
  • autosomal recessive Parkinson's disease 14
  • dystonia-Parkinsonism Adult-onset
  • dystonia-Parkinsonism, adult-onset
  • dystonia-parkinsonism, Paisan-Ruiz type
  • hereditary late onset Parkinson disease caused by mutation in PLA2G6

GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report
OMIM

Online Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.

View report